Structural requirements for the antiproliferative activity of pre-mRNA splicing inhibitor FR901464

FR901464, a natural product isolated from a bacterium source, activates a reporter gene, inhibits pre-mRNA splicing, and shows antitumor activity. We previously reported the development of a more potent analogue, meayamycin, through the total synthesis of FR901464. Herein, we report detailed structure-activity relationships of FR901464 that revealed the significance of the epoxide, carbon atoms in the tetrahydropyran ring, the Z geometry of the side chain, the 1,3-diene moiety, the C4-hydroxy group, and the C2'-carbonyl group. Importantly, the methyl group of the acetyl substituent was found to be inessential, leading to a new potent analogue. Additionally, partially based on in vivo data, we synthesized and evaluated potentially more metabolically stable analogues for their antiproliferative activity. These structural insights into FR901464 may contribute to the simplification of the natural product for further drug development.     

Studies on mimicry of naturally occurring annonaceous acetogenins: non-THF analogues leading to remarkable selective cytotoxicity against human tumor cells

A class of structurally simplified analogues of the naturally occurring annonaceous acetogenins were developed, amongst which some non-THF analogues showed remarkable cytotoxicities against tumor cell lines, as well as good selectivity between human tumor cells and normal cells. The synthetic routes were significantly shortened because of the removal of the chiral centers bearing the THF rings on the natural templates. This simplification also provides access to the parallel synthesis of these mimics by a combinatorial strategy. The remaining stereogenic centers at the positions alpha to the ethereal links were introduced by the Chiron approach from the easily accessible chiral building blocks 6a and/or 6b, made in turn from L-ascorbic acid or D-mannitol, while the one in the butenolide segment was taken from L-lactate. All four diastereomeric non-THF analogues 2a-2d showed remarkable activity against the HCT-8 cell line, and better differentiation was found when testing against the HT-29 cell line. It was also discovered that both the butenolide and ethylene glycol subunits play essential roles in the cytotoxicities against tumor cell lines, while the 10-substituted hydroxy group and the absolute configuration of methyl group at the butenolide moiety are less important for their activity.     

Structure and function of cis-prenyl chain elongating enzymes

All carbon skeletons of isoprenoids, whose chain lengths vary widely from geranyl diphosphate (C10) to natural rubber (C>10,000), are synthesized by sequential condensation of isopentenyl diphosphate with an allylic diphosphate through catalytic functions of a group of enzymes commonly called "prenyltransferases." Prenyltransferases are classified into two major groups, trans- or (E)-prenyltransferases and cis- or (Z)-prenyltransferases, according to the geometry of the prenyl chain units in the products. From the year 1987, many genes encoding trans-prenyltransferases were cloned and clearly characterized. In contrast, the structure and detailed mechanism of cis-prenyltransferase was completely unknown until the identification of a gene encoding the undecaprenyl diphosphate (UPP) synthase from Micrococcus luteus B-P 26 in 1998. Not only the primary but also the tertiary structure of the UPP synthase is quite different from that of the trans-prenyltransferases. Multiple alignment of the primary structures of cis-prenyltransferases identified from various organisms reveals five highly conserved regions. Site-directed mutagenesis of the conserved amino acid residues in UPP synthases based on the crystal structure has elucidated the basic catalytic mechanisms. Moreover, comparison of the structures of short-, medium-, and long-chain cis-prenyltransferases reveals important amino acid residues for product chain length determination, which enabled us to understand the regulation mechanism of the ultimate chain length among cis-prenyltransferases.     

Oral,Direct Thrombin and Factor Xa Inhibitors: The Replacement for Warfarin,Leeches, and Pig Intestines?

To prevent thromboses after surgery, patients have until now had to inject themselves daily with heparin. For stroke prophylaxis in atrial fibrillation, patients take vitamin K antagonists of the coumarin type, which have a narrow therapeutic window and whose dosage must be regularly monitored. In order to improve the standard of therapy in thromboembolic diseases such as deep‐vein thrombosis, pulmonary embolism, and stroke in atrial fibrillation, intensive research has been carried out over the last decade in the search for new, orally active thrombin and factor Xa inhibitors. A number of these compounds are already on the market or are in advanced clinical development; they could revolutionize the anticoagulant market.     

Diaroyl(methanato)boron difluoride compounds as medium-sensitive two-photon fluorescent probes

This paper evaluates the use of diaroyl(methanato)boron difluoride compounds for designing efficient fluorescent probes through two-photon absorption. Three different pathways allowing for the syntheses of symmetrical and dissymmetrical molecules are reported. The stable diaroyl(methanato)boron difluoride derivatives can be easily obtained in good yields. They exhibit a large one-photon absorption that is easily tuned in the near-UV range. Their strong fluorescence emission covers the whole visible domain. In addition to these attractive linear properties, several diaroyl(methanato)boron difluoride derivatives possess significant cross sections for two-photon absorption. The derived structure-property relationships are promising for designing new generations of molecules relying on the diaroyl(methanato)boron difluoride backbone.     

Reactions of ZnR2 compounds with dibenzoyl: characterisation of the alkyl-transfer products and a striking product-inhibition effect

The first systematic theoretical and experimental studies of reaction systems involving ZnR(2) (R=Me, Et or tBu) with dibenzoyl (dbz) as a non-innocent ligand revealed that the character of the metal-bonded R group as well as the ratio of the reagents and the reaction temperature significantly modulate the reaction outcome. DFT calculations showed four stable minima for initial complexes formed between ZnR(2) and dbz and the most stable structure proved to be the 2:1 adduct; among the 1:1 adducts three structural isomers were found of which the most stable complex had the monodentate coordination mode and the chelate complex with the s-cis conformation of the dbz unit appeared to be the least stable form. Interestingly, the reaction involving ZnMe(2) did not lead to any alkylation product, whereas the employment of ZntBu(2) resulted in full conversion of dbz to the O-alkylated product [tBuZn{PhC(O)C(OtBu)Ph}] already at -20 °C. A more complicated system was revealed for the reaction of dbz with ZnEt(2). Treatment of a solution of dbz in toluene with one equivalent of ZnEt(2) at room temperature afforded a mixture of the O- and C-alkylated products [EtZn{PhC(O)C(OEt)Ph}] and [EtZn{OC(Ph)C(O)(Et)Ph}], respectively. The formation of the C-alkylated product was suppressed by decreasing the initial reaction temperature to -20 °C. Moreover, in the case of the dbz/ZnEt(2) system monitoring of the dbz conversion over the entire reaction course revealed a product inhibition effect, which highlights possible participation of multiple equilibria of different zinc alkoxide/ZnEt(2) aggregates. Diffusion NMR studies indicated that dbz forms an adduct with the O-alkylated product, which is a competent species for executing the inhibition of the alkylation event.